Categories
International & World

EU chief: Bloc was late, over-confident on vaccine rollout

European Commission President Ursula von der Leyen speaks during a debate on the united EU approach to COVID-19 vaccinations at the European Parliament in Brussels, Wednesday, Feb. 10, 2021. (Johanna Geron, Pool via AP)

 

BRUSSELS (AP) — As the European Union surpassed 500,000 people lost to the virus, the EU Commission chief said Wednesday that the bloc’s much-criticized vaccine rollout could be partly blamed on the EU being over-optimistic, over-confident and plainly “late.”

European Commission President Ursula von der Leyen defended the EU’s overall approach of trying to beat the pandemic with a unified vaccine plan for its 27 nations, even if she admitted mistakes in the strategy to quickly obtain sufficient vaccines for its 447 million citizens.

“We are still not where we want to be. We were late to authorize. We were too optimistic when it came to massive production and perhaps we were too confident that, what we ordered, would actually be delivered on time,” von der Leyen told the EU parliament.

On the vaccine authorization, which left the EU three weeks behind Britain in starting its vaccination campaign, von der Leyen promised action. She said the EU would launch a clinical trial network and adapt the approval process to get doses quicker from the labs into the arms of a needy population.

“It’s is true there are also lessons to be drawn from the procedure we have followed. And we are already drawing them,” she told legislators.

The European Medicines Agency has approved three coronavirus vaccines for the bloc so far — from Pfizer-BioNTech, Moderna and Oxford-AstraZeneca — and is reviewing others.

Despite weeks of stinging criticism as the EU’s vaccine campaign failed to gain momentum compared to Britain, Israel and the United States, the main parties in the legislature stuck with von der Leyen’s approach of moving forward with all member states together.

“The key decisions were right,” said Manfred Weber, the leader of the Christian Democrat European People’s Party.

The Socialists and Democrats party leader Iratxe Garcia said “Fiasco, catastrophe, disaster: they ring very true to our citizens,” but added her party will stick with von der Leyen on the bloc moving together. “Criticism is necessary but with a constructive spirit.”

Von der Leyen’s assessment came as the bloc’s death toll passed a landmark of 500,000, a stunning statistic in less than a year that fundamentally challenges the bloc’s vaunted welfare standards and health care capabilities.

It came as the bloc was fighting off the remnants of a second surge of COVID-19 that has kept nations from Portugal to Finland under all kinds of lockdowns, curfews and restrictions as authorities race to vaccinate as many people as possible.

The last official weekly figures from the European Centre for Disease Prevention and Control are expected Thursday but Johns Hopkins University produced a daily tally showing EU virus deaths at over 500,800 on Wednesday.

The United States, with a population of 330 million, leads the world’s national virus toll with more than 468,000 deaths.

Von der Leyen stuck with her promise to have 70% of the EU’s adult population vaccinated by the end of summer and blamed big pharmaceutical companies for not keeping vaccine production up high enough.

“Indeed, industry has to match the groundbreaking pace of science,” von der Leyen said. “We fully understand that difficulties will arise in the mass production of vaccines. But Europe has invested billions of euros in capacities in advance, and we urged the member states to plan the vaccine rollout. So now we all need predictability.”

___

Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic,https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

— Associated Press

Categories
Healthcare

Zelis announces 30-Year Healthcare Technology Veteran, R. Andrew Eckert, as new chief executive officer

BEDMINSTER, N.J.–(BUSINESS WIRE)–#GPTWcertified–Zelis, the industry’s leading claims cost and payments optimization platform with proprietary technology and solutions to price, pay and explain healthcare claims, announced that R. Andrew Eckert has joined the company as its new Chief Executive Officer. A 30-year veteran of the healthcare technology industry, Eckert has had a lifelong focus on enabling healthcare innovation and leading strong teams to their full potential.


During his career, Eckert has served as CEO of some of the healthcare industry’s most notable and impactful healthcare technology companies, including TriZetto Corporation, Eclipsys Corporation, and Valence Health. In each case, Eckert helped deliver client success, product and technology innovation and strong growth. Immediately prior to joining Zelis, Eckert was the CEO of Acelity, a global advanced wound care company which was sold to 3M in October 2019. Earlier in his career, Eckert served as CEO of CRC Health Group, a leading behavioral health provider owned by Bain Capital, and SumTotal Systems, a leading education technology software company.

Eckert serves on the Board of Directors of Becton Dickinson, a medical technology company, and as Chair of the Board of Directors of Varian Medical Systems, a radiation oncology treatments and software company.

“Zelis’ mission is to optimize the healthcare payments cycle – which we define as pricing, paying and explaining the claim – on behalf of payors, providers and consumers. Andy’s deep experience leading multiple companies that serve Zelis’ core constituencies, combined with his track record of driving outstanding client success, makes him a terrific choice to lead Zelis going forward,” said Dave Ament, Managing Partner of Parthenon Capital.

“I am delighted that Andy is joining Zelis,” said Devin O’Reilly, Managing Director, Bain Capital. “Andy is a highly seasoned CEO and he will help position the company to grow, innovate, and transform our industry.”

“I’m thrilled to be joining Zelis. We are a heavyweight in healthcare technology and are at the epicenter of solving some of the industry’s most intractable challenges. I believe our company will continue to make a huge impact in making the U.S. healthcare system more understandable and affordable,” said Eckert. “I look forward to further building and strengthening the company’s momentum in serving our clients with innovative solutions.”

About Zelis

Zelis is the healthcare industry’s leading claims cost and payments optimization platform with superior technology and solutions to price claims, pay claims and explain claims, all at enterprise scale on a claim-by-claim basis. Zelis leverages proprietary technology, robust analytics, extensive payment and provider networks, and innovative claim savings channels to deliver to the industry superior administrative and medical cost savings. Zelis was founded on a belief that there is a “better way” to determine the cost of a healthcare claim, manage payment related data, and make the claim payment. Zelis provides the industry’s only comprehensive, integrated platform to take a claim through the entire pre-payment to payments lifecycle. Zelis’ ~1000 associates serve more than 700 payor clients, including the top-5 national health plans, Blues plans, regional health plans, TPAs and self-insured employers, and more than 1.5 million providers. Zelis delivers more than $5B of claims savings, $50B of provider payments and 500 million payment data communications annually, and enjoys a highly recurring revenue model and a strong margin profile.

Contacts

Thuy-An Wilkins

Zelis

908.389.8756

Thuy-An.Wilkins@zelis.com